Compare ADT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADT | BLCO |
|---|---|---|
| Founded | 1874 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.0B |
| IPO Year | 2017 | 2022 |
| Metric | ADT | BLCO |
|---|---|---|
| Price | $6.59 | $16.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $8.38 | ★ $18.55 |
| AVG Volume (30 Days) | ★ 9.3M | 417.3K |
| Earning Date | 03-02-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | ★ 29.63 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,128,607,000.00 | $5,101,000,000.00 |
| Revenue This Year | $5.00 | $8.61 |
| Revenue Next Year | $3.77 | $5.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.70 | ★ 6.47 |
| 52 Week Low | $6.27 | $10.45 |
| 52 Week High | $8.94 | $18.92 |
| Indicator | ADT | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 35.69 | 37.53 |
| Support Level | $6.27 | $14.39 |
| Resistance Level | $8.30 | $17.44 |
| Average True Range (ATR) | 0.24 | 0.53 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 28.81 | 13.66 |
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.